ConductScience.org, home

Trial · NCT00770653

Adverse events58

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherArthralgiaMusculoskeletal and connective tissue disordersPioglitazone 15 mg and Metformin 850 mg BID8153
otherArthralgiaMusculoskeletal and connective tissue disordersGlimepiride 2 mg and Metformin 850 mg BID3149
otherDiarrhoeaGastrointestinal disordersPioglitazone 15 mg and Metformin 850 mg BID14153
otherDiarrhoeaGastrointestinal disordersGlimepiride 2 mg and Metformin 850 mg BID14149
otherHeadacheNervous system disordersPioglitazone 15 mg and Metformin 850 mg BID7153
otherHeadacheNervous system disordersGlimepiride 2 mg and Metformin 850 mg BID7149
otherNasopharyngitisInfections and infestationsPioglitazone 15 mg and Metformin 850 mg BID24153
otherNasopharyngitisInfections and infestationsGlimepiride 2 mg and Metformin 850 mg BID33149
otherOedema peripheralGeneral disordersPioglitazone 15 mg and Metformin 850 mg BID8153
otherOedema peripheralGeneral disordersGlimepiride 2 mg and Metformin 850 mg BID4149
seriousAbdominal adhesionsGastrointestinal disordersPioglitazone 15 mg and Metformin 850 mg BID0153
seriousAbdominal adhesionsGastrointestinal disordersGlimepiride 2 mg and Metformin 850 mg BID1149
seriousBenign breast neoplasmNeoplasms benign, malignant and unspecified (incl cysts and polyps)Pioglitazone 15 mg and Metformin 850 mg BID1153
seriousBenign breast neoplasmNeoplasms benign, malignant and unspecified (incl cysts and polyps)Glimepiride 2 mg and Metformin 850 mg BID0149
seriousCardiac failureCardiac disordersPioglitazone 15 mg and Metformin 850 mg BID2153
seriousCardiac failureCardiac disordersGlimepiride 2 mg and Metformin 850 mg BID0149
seriousCardiomegalyCardiac disordersPioglitazone 15 mg and Metformin 850 mg BID1153
seriousCardiomegalyCardiac disordersGlimepiride 2 mg and Metformin 850 mg BID0149
seriousCarotid artery stenosisNervous system disordersPioglitazone 15 mg and Metformin 850 mg BID0153
seriousCarotid artery stenosisNervous system disordersGlimepiride 2 mg and Metformin 850 mg BID1149

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00770653/events